SOCIOS
VCN BIOSCIENCES SL is the leader of different collaborative projects:
Project Cure4RB project: Development of VCN-01 for pediatric retinoblastoma and Phase 1 clinical trial (RTC-2015-4319-1), in which the following partners have been implied: FUNDACIÓ HOSPITAL SANT JOAN DE DÉU, REIG JOFRÉ GROUP, & INSTITUT CATALÀ D'ONCOLOGIA. This project has received funding from Spanish MINISTERIO DE ECONOMÍA Y COMPETITIVIDAD and the European Union (FEDER) by means of RETOS program in its 2015 call.
Project ADELVAC project: ADENOVIRUS with epitope deletions for vaccinacion (IPT-2012-0551-010000), in which the following partners have been implied: REIG JOFRÉ GROUP, INSTITUT CATALÀ D'ONCOLOGIA & INSTITUTO DE SALUD CARLOS III. This project has received funding from Spanish MINISTERIO DE ECONOMÍA Y COMPETITIVIDAD and the European Union (FEDER) by means of INNPACTO program in its 2012 call la Frase.
Project Cure4RB project: Development of VCN-01 for pediatric retinoblastoma and Phase 1 clinical trial (RTC-2015-4319-1), in which the following partners have been implied: FUNDACIÓ HOSPITAL SANT JOAN DE DÉU, REIG JOFRÉ GROUP, & INSTITUT CATALÀ D'ONCOLOGIA. This project has received funding from Spanish MINISTERIO DE ECONOMÍA Y COMPETITIVIDAD and the European Union (FEDER) by means of RETOS program in its 2015 call.
Project ADELVAC project: ADENOVIRUS with epitope deletions for vaccinacion (IPT-2012-0551-010000), in which the following partners have been implied: REIG JOFRÉ GROUP, INSTITUT CATALÀ D'ONCOLOGIA & INSTITUTO DE SALUD CARLOS III. This project has received funding from Spanish MINISTERIO DE ECONOMÍA Y COMPETITIVIDAD and the European Union (FEDER) by means of INNPACTO program in its 2012 call la Frase.
